Goncharuk AG and Getman M. Benchmarking to improve a strategy and marketing in pharmaceuticals 2014; 21(3): 364–385.
2.
UmemuraM. Crisis and change in the system of innovation: The Japanese pharmaceutical industry during the lost decades, 1990–2010. Bus Hist [serial online]2014; 56(5): 816–844.
3.
WernzCZhangHPhusavatK. International study of technology investment decisions at hospitals. Ind Manage Data Syst [serial online]2014; 114(4): 568–582.
4.
HuebnerJ. Moral psychology and the intuition that pharmaceutical companies have a ‘special' obligation to society. J Bus Ethics [serial online]2014; 122(3): 501–510.
5.
CampartSPfisterE. Technological races and stock market value: Evidence from the pharmaceutical industry. Econ Innov New Technol [serial online]2014; 23(3): 215–238.
6.
LichtenbergFPetterssonB. The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997–2010: Evidence from longitudinal, disease-level data. Econ Innov New Technol2014; 23(3): 239–273.
